ISTH Congress Abstracts

Official abstracts site for the ISTH Congress

MENU 
  • Home
  • Congress Archive
    • ISTH 2022 Congress
    • ISTH 2021 Congress
    • ISTH 2020 Congress
  • Resources
  • Search

A Performance Evaluation of Chemiluminescent-Enzyme Immunoassays on a Routine Coagulation Analyser

C. Gardiner1, P. Lane1, H. Tailor2, S.J. Machin1, I.J. Mackie1

1University College London, Haemostasis Research Unit, London, United Kingdom, 2The Doctors Laboratory (TDL), Haematology, London, United Kingdom

Abstract Number: PB0608

Meeting: ISTH 2020 Congress

Theme: Diagnostics and OMICs » Laboratory Diagnostics

Background: The Sysmex CN-Series haemostasis analysers have integrated haemostasis immunoassay modules that perform chemiluminescent-enzyme immunoassays (CLEIA) in addition to coagulation, turbidimetric, chromogenic and platelet aggregation tests.

Aims: To evaluate the performance the CN-Series CLEIA with the predicate device (Sysmex HISCL-800) for thrombin-antithrombin (TAT), plasmin α2 plasmin inhibitor complex (PIC), tissue plasminogen activator/ plasminogen activator inhibitor 1 complex (t-PAI-C) and thrombomodulin (TM).

Methods: Imprecision was assessed by testing high and low quality control plasmas x10 on each of 5 separate days. Comparability was studied in 230 plasmas from normal donors, patients with suspected disseminated intravascular coagulation, sepsis or liver disease, lipaemic, haemolysed and icteric samples. Linearity, limit of detection and limit of quantitation was determined by testing doubling dilutions of a pooled normal plasma. Carryover was assessed by testing samples with normal plasma and plasmas with TAT and TPAI-C above 100 ng/mL.

Results: The CN-Series performed 26 CLEIA tests per hour (time to first result was < 20 minutes), while simultaneous performing coagulation tests. Acceptable imprecision between-run was obtained for all four assays in high (%CV < 6%) and low (%CV < 7%) controls (Table 1). Excellent linearity was observed (slope 0.89 - 1.03; r2 >0.99) across the measurement range. The lower limits of detection and quantitation were: TM < 0.3/0.6 TU/mL, TAT >0.1/< 0.2 ng/mL, PIC < 0.004/< 0.008 µg/mL and TPAI-C < 0.01/< 0.1 ng/mL respectively. All four assays showed excellent correlation between instruments (Figure 1) and were unaffected by haemolysis, icterus or lipaemia. No carryover was observed in the TAT or TPAI-C assays.

Conclusions: Our data demonstrate that the performance of the CLEIA module of the CN-Series is comparable to that of a stand-alone immunoassay analyser.

High QC Mean HISCL-800 SD HISCL-800 %CV HISCL-800 Mean CN-series SD CN-series %CV CN-series
TAT ng/mL 36.89 1.39 3.77% 38.00 1.59 4.17%
TM TU/mL 113.0 2.5 2.46% 115.0 3.8 3.29%
PIC μg/mL 7.257 0.254 3.49% 6.938 0.280 4.04%
TPAI-C ng/mL 15.59 0.62 3.98% 17.67 0.99 5.62%
Low QC Mean HISCL-800 SD HISCL-800 %CV HISCL-800 Mean CN-series SD CN-series %CV CN-series
TAT ng/mL 9.56 0.32 3.36% 9.69 0.39 4.01%
TM TU/mL 27.4 0.7 2.48% 27.7 0.8 2.93%
PIC μg/mL 1.773 0.056 3.22% 1.620 0.046 2.84%
TPAI-C ng/mL 4.14 0.15 3.75% 4.67 0.31 6.74%

[Table 1]


[Figure 1]

To cite this abstract in AMA style:

Gardiner C, Lane P, Tailor H, Machin SJ, Mackie IJ. A Performance Evaluation of Chemiluminescent-Enzyme Immunoassays on a Routine Coagulation Analyser [abstract]. Res Pract Thromb Haemost. 2020; 4 (Suppl 1). https://abstracts.isth.org/abstract/a-performance-evaluation-of-chemiluminescent-enzyme-immunoassays-on-a-routine-coagulation-analyser/. Accessed September 27, 2023.

« Back to ISTH 2020 Congress

ISTH Congress Abstracts - https://abstracts.isth.org/abstract/a-performance-evaluation-of-chemiluminescent-enzyme-immunoassays-on-a-routine-coagulation-analyser/

Simple Search

Supported By:

Takeda logo

ISTH 2022 Congress site

Visit the official web site for the ISTH 2022 Virtual Congress »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2023 John Wiley & Sons, Inc. All Rights Reserved.
Wiley